Symptoms and diagnosis of local recurrence after rectal cancer treatment

References

• Camilleri-Brennan J, Steele RJ. The impact of recurrent rectal cancer on quality of life. Eur J Surg Oncol. 2001; 27(4):349–353.
   PubMed Web of Science ®Google Scholar
• Kodeda K, Derwinger K, Gustavsson B, et al. Local recurrence of rectal cancer: a population-based cohort study of diagnosis, treatment and outcome. Colorectal Dis. 2012;14(5):e230-7–e237.
   PubMed Web of Science ®Google Scholar
• Denost Q, Faucheron JL, Lefevre JH, et al. French current management and oncological results of locally recurrent rectal cancer. Eur J Surg Oncol. 2015;41(12):1645–1652.
   PubMed Web of Science ®Google Scholar
• Hagemans JAW, van Rees JM, Alberda WJ, et al. Locally recurrent rectal cancer; long-term outcome of curative surgical and non-surgical treatment of 447 consecutive patients in a tertiary referral centre. Eur J Surg Oncol. 2020;46(3):448–454.
   PubMed Web of Science ®Google Scholar
• Jankowski M, Las-Jankowska M, Rutkowski A, et al. Clinical reality and treatment for local recurrence of rectal cancer: a single-center retrospective study. Medicina (Kaunas). 2021;57(3):286.
   PubMed Web of Science ®Google Scholar
• Matsuyama T, Yamauchi S, Masuda T, Japanese Study Group for Postoperative Follow-up of Colorectal Cancer, et al. Treatment and subsequent prognosis in locally recurrent rectal cancer: a multicenter retrospective study of 498 patients. Int J Colorectal Dis. 2021;36(6):1243–1250.
   PubMed Web of Science ®Google Scholar
• Jeffery M, Hickey BE, Hider PN. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev. 2019;9(9):Cd002200.
   PubMed Web of Science ®Google Scholar
• Verberne CJ, Zhan Z, van den Heuvel E, et al. Intensified follow-up in colorectal cancer patients using frequent Carcino-Embryonic antigen (CEA) measurements and CEA-triggered imaging: results of the randomized "CEAwatch" trial. Eur J Surg Oncol. 2015;41(9):1188–1196.
   PubMed Web of Science ®Google Scholar
• Pita-Fernández S, Alhayek-Aí M, González-Martín C, et al. Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: a systematic review and meta-analysis. Ann Oncol. 2015;26(4):644–656.
   PubMed Web of Science ®Google Scholar
• Primrose JN, Perera R, Gray A, FACS Trial Investigators, et al. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. JAMA. 2014;311(3):263–270.
   PubMed Web of Science ®Google Scholar
• Wille-Jørgensen P, Syk I, Smedh K, COLOFOL Study Group, et al. Effect of more vs less frequent follow-up testing on overall and colorectal cancer-specific mortality in patients with stage II or III colorectal cancer: the COLOFOL randomized clinical trial. JAMA. 2018; 19(20):2095–2103.
   Web of Science ®Google Scholar
• Rosati G, Ambrosini G, Barni S, GILDA working group, et al. A randomized trial of intensive versus minimal surveillance of patients with resected dukes B2-C colorectal carcinoma. Ann Oncol. 2016;27(2):274–280.
   PubMed Web of Science ®Google Scholar
• Maurer CA, Renzulli P, Kull C, et al. The impact of the introduction of total mesorectal excision on local recurrence rate and survival in rectal cancer: long-term results. Ann Surg Oncol. 2011;18(7):1899–1906.
   PubMed Web of Science ®Google Scholar
• den Dulk M, Krijnen P, Marijnen CA, et al. Improved overall survival for patients with rectal cancer since 1990: the effects of TME surgery and pre-operative radiotherapy. Eur J Cancer. 2008;44(12):1710–1716.
   PubMed Web of Science ®Google Scholar
• Bernardshaw SV, Ovrebo K, Eide GE, et al. Treatment of rectal cancer: reduction of local recurrence after the introduction of TME - experience from one university hospital. Dig Surg. 2006;23(1-2):51–59.
   PubMed Web of Science ®Google Scholar
• Folkesson J, Birgisson H, Pahlman L, et al. Swedish rectal cancer trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol. 2005;23(24):5644–5650.
   PubMed Web of Science ®Google Scholar
• van Gijn W, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011;12(6):575–582.
   PubMed Web of Science ®Google Scholar
• Swedish ColoRectal Cancer Registry. Rectal Cancer 2019 - National quality report for the year 2019 from the Swedish ColoRectal Cancer Registry. [Internet]. 2020. [cited 2020 Dec 12]. Avaliabel from: https://www.cancercentrum.se/globalassets/cancerdiagnoser/tjock–och-andtarm-anal/kvalitetsregister/tjock–och-andtarm-2020/rektalrapport-2019.pdf.
   Google Scholar
• Kodeda K, Johansson R, Zar N, et al. Time trends, improvements and national auditing of rectal cancer management over an 18-year period. Colorectal Dis. 2015;17(9):O168–79.
   PubMed Web of Science ®Google Scholar
• Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019;14(2):89–103.
   PubMed Web of Science ®Google Scholar
• Glynne-Jones R, Wyrwicz L, Tiret E, ESMO Guidelines Committee, et al. Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(suppl_4):iv22–iv40.
   PubMed Web of Science ®Google Scholar
• Martin LA, Gross ME, Mone MC, et al. Routine endoscopic surveillance for local recurrence of rectal cancer is futile. Am J Surg. 2015;210(6):996–1001. discussion 1001–2.
   PubMed Web of Science ®Google Scholar
• Tronstad PK, Simpson LVH, Olsen B, et al. Low rate of local recurrence detection by rectoscopy in follow-up of rectal cancer. Colorectal Dis. 2020;22(3):254–260.
   PubMed Web of Science ®Google Scholar
• Regional Cancer Centers in Collaboration. Swedish National Care Program for ColoRectal Cancer. 2021.
   Google Scholar
• Sørensen CG, Karlsson WK, Pommergaard HC, et al. The diagnostic accuracy of carcinoembryonic antigen to detect colorectal cancer recurrence - A systematic review. Int J Surg. 2016;25:134–144.
   PubMed Web of Science ®Google Scholar
• Nicholson BD, Shinkins B, Pathiraja I, et al. Blood CEA levels for detecting recurrent colorectal cancer. Cochrane Database Syst Rev. 2015;2015(12):CD011134.
   Web of Science ®Google Scholar
• Mathai RA, Vidya RVS, Reddy BS, et al. Potential utility of liquid biopsy as a diagnostic and prognostic tool for the assessment of solid tumors: implications in the precision oncology. J Clin Med. 2019;8(3):373.
   PubMed Web of Science ®Google Scholar
• Diehl F, Li M, Dressman D, et al. Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc Natl Acad Sci U S A. 2005;102(45):16368–16373.
   PubMed Web of Science ®Google Scholar
• Registry SCC. Rectal Cancer 2018 - National Quality Report for the year 2018 [Internet]2018.
   Google Scholar
• Asplund D, Heath J, González E, et al. Self-reported quality of life and functional outcome in patients with rectal cancer–QoLiRECT. Dan Med J. 2014 May;61(5):A4841.
   PubMed Web of Science ®Google Scholar
• Cleeland CS, Ryan KM. Pain assessment: global use of the brief pain inventory. Ann Acad Med Singap. 1994;23(2):129–138.
   PubMedGoogle Scholar
• Westberg K, Palmer G, Johansson H, et al. Time to local recurrence as a prognostic factor in patients with rectal cancer. Eur J Surg Oncol. 2015;41(5):659–666.
   PubMed Web of Science ®Google Scholar
• Westberg K, Palmer G, Hjern F, et al. Population-based study of factors predicting treatment intention in patients with locally recurrent rectal cancer. Br J Surg. 2017;104(13):1866–1873.
   PubMed Web of Science ®Google Scholar
• Denis F, Yossi S, Septans AL, et al. Improving survival in patients treated for a lung cancer using self-evaluated symptoms reported through a web application. Am J Clin Oncol. 2017;40(5):464–469.
   PubMed Web of Science ®Google Scholar
• Lampic C, Wennberg A, Schill JE, et al. Anxiety and cancer-related worry of cancer patients at routine follow-up visits. Acta Oncol. 1994;33(2):119–125.
   PubMed Web of Science ®Google Scholar
• Nordin K, Glimelius B, Påhlman L, et al. Anxiety, depression and worry in gastrointestinal cancer patients attending medical follow-up control visits. Acta Oncol. 1996;35(4):411–416.
   PubMed Web of Science ®Google Scholar
• Kudose Y, Shida D, Ahiko Y, et al. Evaluation of recurrence risk After curative resection for patients With stage I to III colorectal cancer using the hazard function: Retrospective analysis of a single-institution large cohort. Ann Surg. 2022;275(4):727–734.
   PubMed Web of Science ®Google Scholar
• Waldenstedt S, Bock D, Haglind E, et al. Intraoperative adverse events as a risk factor for local recurrence of rectal cancer after resection surgery. Colorectal Dis. 2022;24(4):449–460.
   PubMed Web of Science ®Google Scholar
• Palmer G, Martling A, Cedermark B, et al. Preoperative tumour staging with multidisciplinary team assessment improves the outcome in locally advanced primary rectal cancer. Colorectal Dis. 2011;13(12):1361–1369.
   PubMed Web of Science ®Google Scholar